Phase 1 Hepatitis B Virus Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting
Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
Hepatitis B Virus Infection
GigaGen, Inc.48 enrolled16 locationsNCT07024641
Recruiting
Phase 1
A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
Chronic Hepatitis B Virus Infection
IntegerBio90 enrolled1 locationNCT07389044
Recruiting
Phase 1Phase 2
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
SCG Cell Therapy Pte. Ltd.46 enrolled6 locationsNCT05417932
Recruiting
Phase 1
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000
Completed
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB).
Chronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.40 enrolled8 locationsACTRN12623000078651
Completed
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers.
Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc32 enrolled1 locationACTRN12623000075684
Completed
Phase 1
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food on GS 9688
Hepatitis B Virus
Gilead Sciences, Inc.102 enrolled1 locationACTRN12616001646437
Terminated
Phase 1
A study to evaluate safety and tolerability of GS -5801 in healthy subjects
Hepatitis B Virus
Gilead Sciences, Inc.70 enrolled1 locationACTRN12616001260415